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INTRODUCTION
The lower urinary tract consists of the bladder and the urethra, which contain smooth and striated 
muscles, supported by other muscles and ligaments. 
The urothelium is described as the inner lining of the 
bladder, with a barrier function. According to the Inter-
national Continence Society (ICS), lower urinary tract 
symptoms (LUTS) can be divided into storage, voiding, 
and post-micturition symptoms. In male patients, LUTS 
are usually attributed to benign prostatic enlargement 
and bladder outlet obstruction, whereas in female pa-
tients, it is predominantly associated with overactive 
bladder syndrome (OAB).(1-3)
In recent years, with the application of novel urinalysis 
methods, urine is no longer considered to be sterile, as 
a certain microbiome was detected in healthy, asympto-
matic individuals. This finding provided a new horizon 
for detecting the causes and treatments of LUTS.(4, 5) An 
integral part of the microbiome is the microbiota, which 
refers to the assemblage of living microorganisms in 
a defined environment.(7) The term “microbiome” can 
be used to represent microorganisms (i.e., bacteria, ar-
chaea, lower and higher eukaryotes, and viruses), their 
habitats, their genomes, and their surrounding environ-
mental conditions.(8)
The Human Microbiome Project (HMP) investigated 
the microbiota communities in the human body. How-
ever, they mostly focused on organs, such as the skin, 
mouth, genital tract, eyes, gut, and blood. Also, the cor-
relation of urinary microbiome with LUTS has been the 
subject of investigation in many studies.(6) In this study, 
we aimed to present an overview of the published lit-
erature on the relationship between urinary microbiota 
and different disorders of the genitourinary system, in-
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cluding LUTS, bladder pain syndrome (BPS), prostati-
tis, kidney stone disease, and bladder cancer (Table 1).
Until recently, the urine of healthy individuals was as-
sumed to be sterile. The sterility of healthy urine was 
thought to be maintained by host factors, such as phys-
ical barriers between the source of pathogenic bacteria 
and the urinary tract, the ongoing flow of urine through 
the urinary tract, and complete bladder emptying during 
voiding. These factors, along with antibodies, proteins, 
and other factors, which destroy or restrict the ability 
of microbes to grow, should prevent infection.(7) The 
uroepithelial defense is the main mechanism, prevent-
ing bacterial growth and infection. Since the epithelial 
cell lining releases Tamm-Horsfall protein, lactoferrin, 
and lipocalin, in addition to constitutive and inducible 
antimicrobial peptides and cathelicidin, the urinary tract 
can prevent the attachment of transient bacteria under 
healthy conditions.(8,9) The frequent absence of bacte-
rial growth in the urine cultures of asymptomatic in-
dividuals, as well as diagnostic settings, has led to the 
assumption of urine sterility. However, recent studies, 
using new techniques, have introduced bacterial mark-
ers in voided urine, which was found to be sterile, based 
on conventional laboratory cultures.(8,9) Therefore, the 
urine is now established as unsterile. Overall, the dif-
ferences of urinary microbiota between fit, ambulatory 
individuals and patients with LUTS may propose an 
etiological principle for numerous bladder disorders.(10)
MATERIALS AND METHODS
Data Sources and Searches
We searched Medline (PubMed), Embase, The 
Cochrane library, Web of Science, Scopus and Pro-
Quest to identify RCTs published, with MeSH, Emtree 
and free keywords including microbiota, lower urinary 
tract symptoms, bladder pain syndrome, prostatitis, 
kidney stone, bladder cancer, viruses, Bacteriophages, 
Fungi, until September 2020. Randomized controlled 
trials investigating microbiome and lower urinary tract 
symptoms were included. The complete search strategy 
is attached in appendix 1. 
Study Selection
Two reviewers screened titles and abstracts to identify 
the relevant studies. Disagreements between two revie-
wrs were resolved through discussion or by the assis-
tance of a third reviewer. The selected abstracts were 
then included for the full-text screening.
Data Extraction
We extracted the demographic characteristics of the 
articles including name of the author, publishing year, 
sample collection, analysis technique, and assosiated 
microbiom.
Risk of Bias Assessment
Two reviewers independently selected the evidence. In 
case of disagreement, a third reviewer re-evaluated the 
documents to solve the discrepancies. 
Data Presentation
The data found, are presented in the results section and 
ordered in subheadings starting with what is known on 
microbiome, the different species and their relationship 
to LUTS, followed by what is known on different uro-
logical conditions that cause LUTS and their relation to 
the urinary microbiome. 
RESULTS
We initially identified 4004 records using the search 
strategy, of which 2464 articles remained after the re-
moval of duplications. Also, 2339 articles did not meet 
Figure 1. Search and selection process of systematic review.
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the inclusion criteria and were removed after screen-
ing for eligibility by reading the titles and abstracts, 
125 fulltexts were assessed further by the exclusion of 
another 111 papers. Finally, a total of 13 studies were 
included in this systematic review. Figure 1 shows the 
details of the study selection process. Table 1, shows 
the characteristics of the included studies.
Microbiome
The term “microbiota” refers to a collection or com-
munity of microbes. The term “microbiome” refers to 
the entire collection of genes found in all microbes.(11,12) 
Despite the common misuse of these two terms, they 
carry distinct meanings, highlighting their careful use. 
Microbial populations are present in the human body 
and reside in different organs, such as the gastroin-
testinal tract, skin, upper respiratory tract, and genital 
tract.(11) There are different elements contributing to the 
shape characteristics of the microbiome communities in 
the body, including age, gender, hormonal status, body 
mass index (BMI), diet, environment, host genetics, and 
early microbial exposure.(7,13-15)
Moreover, the beneficial or pathogenic nature of bacte-
rial populations is a relative concept, depending on the 
individual’s microbiome characteristics.(16,17) Generally, 
maintenance of a normal microbiome is thought to be 
essential in the intestines and probably the bladder.(18) 
Also, it may have an impact on the risk of infection, 
caused by pathogenic organisms, as well as the occur-
rence of immune-mediated diseases and carcinogene-
sis.(19)
Detection of Urinary Bacteria
From the 1950’s until the present day, standard urine 
culture (SUC) has been the routine protocol for identi-
fying pathogenic bacteria in the urine of LUTS patients. 
(20, 21) Commonly, SUC is performed in a clinical 
laboratory by plating 1 µL of urine onto blood and 
MacConkey agar plates and incubating aerobically at 
35˚C for 24 hours. Since the introduction of the original 
method, SUC has been applied as the standard diagnos-
tic tool for identifying urinary tract infections (UTIs), 
although some investigators have reported several dis-
advantages of this method.(22,23)
Laboratories generally rely on standard urine culture 
protocols for detecting frequent, quickly growing aer-
obic uropathogens, particularly uropathogenic Escheri-
chia coli (UPEC).(24) Also, UTIs may be caused by other 
Gram-negative bacteria, such as Pseudomonas aerugi-
nosa, several Enterobacteriaceae species (e.g., common 
Proteus and Klebsiella species), several Gram-positive 
bacteria (e.g., Staphylococcus saprophyticus and En-
terococcus faecalis), and certain fungi (e.g., Candida 
species).(25,26)
Moreover, many other microorganisms have been clas-
sified as emerging uropathogens.(27,28) These microor-
ganisms have been discovered with high colony counts 
in patients with UTI symptoms and/or acute cystitis. 
Nevertheless, these methods cannot detect the presence 
of certain bacteria, such as anaerobic bacteria, bacteria 
embedded within biofilms, commensals or symbionts, 
and genera, such as Corynebacterium, Lactobacillus, 
and Ureaplasma(5,17). Also, they cannot effectively de-
tect urinary microbiota members, including many uro-
pathogens. This necessitates the use of enhanced urine 
culture techniques, which are better correlated with 
methods, such as DNA sequencing and culture-inde-
pendent assays (e.g., diagnostic PCR assay). 
To document the female urinary microbiota more spe-
cifically, many researchers have used the next genera-
tion sequencing (NGS) technique of 16S rDNA. In this 
regard, a previous study used NGS to examine the urine 
samples of subjects, collected by transurethral catheter-
ization and suprapubic aspiration. The results indicated 
the presence of a resident bladder microbiome rather 
Figure 2. The urinary microbiota
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than a vulvovaginal contamination in the collected sam-
ples.(29)
Detection of Urinary Microbiota
Culture-independent methods, particularly 16S rRNA 
gene sequencing, were primarily used in HMP(17,30) to 
elucidate the composition of microbial communities in 
different microbial niches of the human body. In addi-
tion, NGS was employed in many studies to describe 
the microbiota in urine, collected from the bladder of 
individuals with and without LUTS.(31-33) To fully com-
prehend the results of studies on urinary microbiome, 
we must consider the following collection techniques: 
A) collection of midstream voided urine, either with or 
without a clean catch, after cleaning the skin; B) sam-
Table 1. The Summary of studies on the relationship between urinary microbiota and the genitourinary tract
OAB Overactive bladder syndrome, IC Interstitial Cystitis, CP Chronic Prostatitis, CPPS Chronic Pelvic Pain, BC Bladder Cancer, UUI 
Urgency Urinary Incontinence, BPS Bladder Pain Syndrome, LUTS Lower Urinary Tract Symptoms, EQUC Enhanced Quantitative 
Urine Culture, TUC Transurethral Catheterisation, CC Clean Catch Urine, MSU Midstream Urine, SPA Suprapubic aspirate.
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pling up the urethra or using transurethral catheteriza-
tion; and C) suprapubic aspiration of urine.(34)
Although sequencing is a sensitive method, it cannot 
quantify the detected organisms or determine whether 
the bacteria are alive or dead. On the other hand, this 
method provides information about the presence of 
DNA in microbes, which requires non-standard culture 
conditions and cannot be detected otherwise. Enhanced 
quantitative urine culture (EQUC) protocols have been 
expanded to overcome this limitation. 
Bacteriophages and LUTS
In addition to bacteria, viruses and eukaryotic micro-
organisms (i.e., archaea and fungi) are also included in 
microbial communities colonizing the body, with con-
tinuous and intricate interactions with one another and 
the surrounding human niche. Bacterial viruses (bacte-
riophages) play a significant role in microbial commu-
nity dynamics.(35,36) Extensive research into the hetero-
geneity of phages, residing in the bladder, can provide 
important information about changes in the microbial 
community of the bladder.(37-40) Also, similar investiga-
tions have been conducted on the vaginal microbiota.(41)
Moreover, Lactobacillus phages seem to contribute to 
structural changes in the vaginal microbial communi-
ty and improve bacterial vaginosis.(42) The abundance 
of lysogenic phages in the bladder shows that phages 
may be possible contributors to the stability of urinary 
microbiota. In addition, changes in the phage popula-
tions of bacterial strains, isolated from patients without 
OAB symptoms, suggest that phages can contribute to 
urinary health; however, the results are not of great sta-
tistical importance.(43)
Actinomycetaceae phages have been found in strains, 
isolated from women with OAB. Moreover, in a pre-
vious study, a Varibaculum cambriense strain was col-
lected from a female patient with stress urinary incon-
tinence. On the other hand, Actinomycetaceae phages 
were not detected in any Actinomyces strains from the 
asymptomatic controls. In vitro studies have document-
ed how phages can develop intrinsic lytic activities for 
bacteria, collected from patients with UTI due to a spi-
nal cord injury. In addition, resistance optimization is 
achievable through immediate adaptation of bacterio-
phages.(44) 
Additionally, phages can degrade uropathogenic E. 
coli biofilms.(45) Also, use of phages for the treatment 
of UTI has been reported ;(46) therefore, they may be 
regarded as the best option for the prevention and treat-
ment of UTI.(47) Nonetheless, there are certain negative 
aspects to phages. One major disadvantage is second-
ary infection, which refers to virion interactions with 
already phage-infected bacteria, resulting in the so-
called “superinfection exclusion”.(48) Matching phages 
are commonly collected from phage banks, which are 
assemblages of already characterized phage isolates. 
However, it should be noted that in vitro phage activity 
is not consistently predictive of in vivo therapeutic effi-
cacy (i.e., immune responses).(49) 
Overall, phages have many beneficial properties, and 
phage therapy has limited side effects. The presence 
of phages with significant sequence similarity in the 
microbiota of women suggests the presence of a fun-
damental phage community within the bladder. In ad-
dition, oscillation of phage populations in women with 
and without OAB symptoms shows that phages can im-
prove urinary health.(43)
Viruses and LUTS
Hantaviruses, which have been recently introduced as 
common viruses in Europe,(50) can cause severe Hanta-
virus diseases, with a mortality rate of approximately 
15%. These viruses, which belong to the Bunyaviridae 
family and contribute to the development of kidney fail-
ure, cause a group of clinically similar diseases, known 
as Hemorrhagic Fever with Renal Syndrome (HFRS). 
HFRS is mainly caused by some Old-World Hantavi-
ruses, including Hantaan orthohantavirus, Seoul or-
thohantavirus, Dobrava-Belgrade orthohantavirus, and 
Puumala orthohantavirus. These viruses are associated 
with renal dysfunction, hemorrhage, fever, thrombocy-
topenia, acute renal insufficiency, abdominal pain, and 
occasional acute pancreatitis. The diagnosis of Hanta-
virus infections is based on immunofluorescence assays 
using virus-infected cells, enzyme immunoassays, and 
Western blot analysis with nucleocapsid recombinant 
proteins.(51) 
During 2001-2003, almost 200 clinically apparent 
hantavirus infections were registered annually in Ger-
many.(50) Neutralization assays have indicated almost 
exclusively human infections, caused by Puumala and 
Dobrava Hantaviruses and rarely by Tula Hantavirus. 
However, further explorations are needed to develop a 
more precise concept regarding the distribution of Han-
taviruses in Germany and to calculate the risk for the 
human population. Human papillomavirus infection, 
causing condyloma acuminate, is another example of 
viral infection and consecutive LUTS. It is also recog-
nized as a rarely viral infectious cause of acute urinary 
retention in women.(50) Urethral condyloma can be ef-
fectively treated by local excision for early improve-
ment of voiding function.(52) 
Herpes zoster can involve the spinal cord and anterior 
horn cells, causing various neurological disorders. In-
volvement of the sacral center, leading to bladder dys-
function and urological changes, has been reported to 
be unusual, and its acute type is mainly reported in men. 
This finding was reported for the first time in 1890.(53) 
However, a limited number of cases (~150) has been 
reported over the years. Another virus, correlated with 
urinary tract symptoms, is the human T-cell leukemia 
virus-type 1 (HTLV-1). Nevertheless, the majority of 
patients infected with this virus are carriers, despite 
having multiple urinary symptoms of OAB, which are 
common in HTLV-1-associated myelopathy/tropical 
spastic paraparesis (HAM/TSP). In this regard, a previ-
ous study concluded that some immunological and vi-
ral factors, as well as proviral profiles, can be found in 
patients with HAM/TSP. Another conclusion was that 
HTLV-1 overactive bladder patients are still able to 
down regulate their inflammatory immune response.(54)
Fungi and LUTS
The fungal microbiota have been rarely studied in the 
literature. Mycobiome is a lesser-known, but signifi-
cant aspect of the human microbial ecosystem. Gener-
ally, the pathogenic nature of such organisms is vivid. 
Aberrant fungal infections of the urinary tract may be 
life-threatening due to limitations of culture studies, 
low suspicion of fungal involvement, and absence of 
preventative and therapeutic options.(55) Candida spe-
cies are the most ubiquitously found urinary pathogens. 
Nevertheless, common invasive fungal species, such as 
Cryptococcus, Aspergillus, Mucoraceae, Histoplasma, 
Blastomyces, and Coccidioides, can also infect the uri-
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nary tract. These fungi can attach to the urothelium to 
form mixed biofilms with bacteria or grow in soluble 
microcolonies in the urine, without any direct contact 
with the urothelium. 
There is a possibility that fungi remain quiescent in the 
bladder wall cells, as can be seen in the intracellular 
bacterial colonies of E. coli.(56) Today, the most recur-
rent nosocomial fungal infection is the urinary tract 
candidiasis, which results in the development of UTI. 
Meanwhile, proliferation of Candida species in urinary 
tract candidiasis may lead to the development of anti-
fungal-resistant Candida species. Candida albicans is 
the dominant species, responsible for urinary tract can-
didiasis. 
To prevent, control, and treat urinary tract candidiasis, 
it is essential to monitor Candida species, accounting 
for UTIs.(57) With an optimistic view and a better un-
derstanding of the function of fungi in UTIs, we can 
exercise targeted manipulation of mycobiome for ther-
apeutic applications, as shown in other organ systems. 
Saccharomyces boulardii is currently under trial as a 
probiotic for the treatment of diarrheal diseases.(58-60)
Urinary Tract Infection (UTI)
UTI, as an acute urinary disease, refers to the presence 
or predominance of uropathogenic microbes within the 
bladder, the urethra, or the upper urinary tracts (i.e., 
kidneys and ureters). Gram-negative bacteria, includ-
ing E. coli and K. pneumoniae, are the most common 
uropathogenic bacteria, causing UTI.(61) Recent reviews 
have demonstrated the importance of screening meth-
ods and diagnostic tools for uncomplicated UTI.(62) 
These reviews concentrated on the relationship between 
exposure to organisms and human diseases, in addition 
to the host response. According to 16S rRNA gene se-
quencing, light microscopy, and bacterial culture, bac-
terial DNA inhabits the bladder of adult women with or 
without UTI.(29)
Researchers have conducted comprehensive studies 
to incubate E. coli and E. faecalis with Lactobacillus, 
which is a well-represented member of the genitouri-
nary system microbiome, containing human bladder 
epithelial cells. Evidence suggests a decrease in the uro-
pathogen adherence via incubation with Lactobacillus; 
this decline seems to be correlated with a lower pH. Fi-
nally, these findings may be attributed to some factors, 
such as decreased uropathogen adherence in a more 
acidic environment or higher activities of antimicrobial 
peptides (AMPs) as products of the innate immune sys-
tem, promoted by Lactobacillus.(63,64)
Microbiome and OAB
Urinary urgency is an epicentric symptom of OAB, 
characterized by an abrupt and compelling desire to 
void.(3) Although this symptom is underreported and 
undertreated, it has significant effects on one’s quality 
of life, sleep, sexual function, and mental health.(65) This 
so-called “hidden condition” is also a diagnosis of ex-
clusion for ruling out other symptoms. Urine culture is 
used to rule out infections in patients with OAB symp-
toms. It is possible that microbes, inhabiting the lower 
urinary tract (urinary microbiota), influence the OAB 
symptoms.(4)
Following the discovery of urinary microbiome, 16S 
RNA gene sequencing has been used to determine if 
bacteria, not discovered previously in the urinary tract, 
can plainly or circuitously contribute to or result from 
OAB.(13) This method, along with EQUC, has been used 
to compare urine catheterization between women with 
and without urgency urinary incontinence (UUI). The 
results suggest the possibility of significant contrasts 
in the urinary microbiome of women with and without 
UUI, which can have significant effects on the preven-
tion, diagnosis, and treatment of UUI. 
In another study, more Lactobacillus species were 
found in individuals without UUI, compared to cohorts 
with UUI, whereas in UUI patients, more Gardnerella 
species were found.(13) According to these results, we 
can conclude that Lactobacillus is a member of the nor-
mal vaginal flora, with distinct functions in the bladder. 
A similar scenario might be also true for Gardnerella, 
which was detected more frequently in UUI patients. 
Also, an increased sequence abundance was found in 
the UUI cohort, compared to the non-UUI cohort. Since 
Gardnerella was detected in the urine of women with-
out UUI, the mere presence of Gardnerella might not 
represent a dysbiotic environment.(13) Moreover, bac-
terial genera, including Actinobaculum, Actinomyces, 
Aerococcus, Arthrobacter, Corynebacterium, Oligella, 
Staphylococcus, and Streptococcus, had higher fre-
quencies in the UUI cohort. L. gasseri was found to be 
related to UUI, whereas L. crispatus was detected in 
women without LUTS.(13) 
A study using 16S rRNA gene sequencing of catheter 
specimens of urine, collected from women with UUI, 
without treatment, showed that more than one-half of 
the samples tested positive for bacterial DNA, and the 
positive results were associated with younger age, high-
er BMI, more severe UUI, better response to treatment, 
and lower susceptibility to UTI.(32) Also, Lactobacil-
lus species were detected in urine samples, and Gard-
nerella was the second most frequently detected genus.
(32) These results suggest that some bacteria may have 
protective effects on the bladder, as they do so in other 
human biological niches.
In previous studies, the results of 16S rRNA gene se-
quencing of the urine samples of OAB patients and 
the controls indicated a diversity in the classification 
of detected bacteria. Seven genera, including Proteus 
and Aerococcus, were increased, whereas 13 genera, 
including Lactobacillus and Prevotella, were decreased 
in OAB patients, compared to the controls.(4,66) Other 
researchers have proposed that an increase in the sever-
ity of OAB symptoms is associated with the reduction 
of microbial miscellany.(33) On the other hand, another 
study demonstrated a relationship between the OAB 
symptoms and pyuria. Also, notable urinary urgency 
was correlated with pyuria and epithelial cell shedding. 
In this study, routine urine cultures could not distin-
guish OAB patients from the controls.(67)
In a more recent study, researchers examined the urinary 
microbiome of a female OAB patient via high-through-
put pyrosequencing of 16S rDNA in successive urine 
samples, which were collected within a one-year inter-
val. In the first sample, the standard urine culture was 
positive for Streptococcus. Accordingly, the patient re-
ceived an antibiotic treatment, and one year later, the 
standard urine culture was found to be negative; howev-
er, the urinary symptoms were still reported. The pres-
ence of fastidious and anaerobic bacteria was detected 
by 16S rDNA sequencing of urine samples, with insig-
nificant variations in microbial diversity over one year. 
Therefore, the relatively sustained microbiome and 
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persistence of urinary symptoms, regardless of antibi-
otic treatment, indicated a possible association between 
OAB and urinary microbiota.(68) 
On the other hand, a later publication concluded that 
UUI patients, who responded to treatment, were more 
likely to have less diverse bacteria in their urine, and a 
relationship was proposed between urinary microbiota 
and response to incontinence medications.(69) Overall, 
based on the results of available studies, it may be sug-
gested that Lactobacillus plays a preventive role against 
UUI. These findings can have significant implications 
for the future diagnosis, treatment, and prevention of 
UUI.
Microbiome and Bladder Pain Syndrome (BPS)/
Interstitial Cystitis (IC)
BPS or IC is described as “the complaint of suprapubic 
pain, related to bladder filling accompanied by other 
symptoms, such as increased daytime and nighttime 
frequency in the absence of urinary infection or other 
obvious pathologies of the lower urinary tract”.(1) The 
BPS/IC symptoms are reminiscent of infection, with 
UTI often accompanying this condition. Therefore, in 
clinical practice, the diagnostic process is often prone 
to explicit falsification, and an inaccurate diagnosis can 
lead to chronic pain syndrome and treatment resistance. 
(70) 
In this regard, a previous study examined the assump-
tion that BPS/IC has no relationship with bacterial 
colonization. For this purpose, 16S rDNA sequencing 
was performed on clean-catch urine samples, and the 
urinary microbiota of BPS/IC patients were character-
ized and compared with the urine samples of healthy 
women. Although no specific pathogen was detected 
for BPS/IC, the results demonstrated a major contrast 
in the bacterial composition of the two groups.(71) In this 
study, the composition of urinary microbiota changed, 
the microbial diversity decreased, and more Lactoba-
cillus species were found in female patients with BPS/
IC, compared to healthy women.(72,73) Also, in BPS/IC 
women, fewer genera were detected, compared to the 
healthy controls (31 vs. 45). Overall, Lactobacillus was 
the most commonly detected genus (92% of sequences 
in BPS/IC patients vs. 57% of sequences in healthy fe-
males), followed by Gardnerella (2%) and Corynebac-
terium (2%). 
In another study, the frequency of genus Corynebacte-
rium decreased in patients, compared to the controls.(74) 
BPS/IC may be associated with a specific microbiome 
of the genitourinary system. Moreover, in a study on 
premenopausal women with BPS/IC and the healthy 
controls, Lactobacilli, with anaerobic or fastidious dom-
inance, was observed in both cohorts. In other words, 
premenopausal women with BPS/IC were not signifi-
cantly different from those without BPS/IC in terms of 
urinary and vaginal microbiomes, although their socio-
economic characteristics and pelvic floor functions had 
deteriorated.(75)
A more recent study examined the urinary microbio-
ta of female patients, suffering from urologic chronic 
pelvic pain syndrome, with symptom flares and stand-
ard negative urine cultures. Two urine samples were 
collected from all subjects, including an initial stream 
urine (VB1) sample and a clean-catch midstream urine 
(VB2) sample. These samples were observed using mo-
lecular methods, which focused on bacterial and fungal 
DNA. At the genus level, Lactobacillus decreased in 
both groups, followed by Staphylococcus in VB1 and 
Propionibacterium in VB2 samples. The significant 
prevalence of fungi (Candida and Saccharomyces) was 
reported in BPS/IC women with symptom flares, com-
pared to those who did not experience any symptom 
exacerbation; this result suggests the involvement of 
these fungi in the pathogenesis of a subtype of BSP/IC, 
associated with symptom flares.(73) 
Recent developments suggest that microbiome can be 
of great significance in BPS/IC, as the role of certain 
Lactobacillus species in the healthy bladder milieu is 
now more evident than ever.(76) However, in another 
study, a hypothesis was made as to how BPS/IC symp-
toms could not be possibly related to variations in the 
urinary microbiome.(77) These results indicate the need 
for further research to reach a better understanding of 
this matter. 
Microbiome and Chronic Prostatitis (CP)/ Male 
Chronic Pelvic Pain Syndrome (CPPS)
CP/CPPS refers to chronic pain and discomfort in the 
pelvic area, commonly correlated with LUTS, sexual 
dysfunction, and psychosocial problems. It commonly 
lasts for a minimum of 3-6 months, with significant im-
pacts on the person’s quality of life and financial bur-
den.(78) A study using 16S rRNA sequencing showed 
that the total bacterial diversity was considerably higher 
in the CP/CPPS group, compared to the controls. Many 
bacterial classes (e.g., Clostridiales and Bacteroidetes) 
were overrepresented in CP/CPPS patients, whereas 
other bacterial classes, such as Bacilli, were underrep-
resented. Also, the anaerobic bacteria were much more 
common in CP/CPPS patients, compared to the con-
trols. This group of bacteria is related to potential path-
ogens, which are not often cultured or treated in regular 
clinical practice. In addition, a greater phylogenetic di-
versity was reported in CP/CPPS patients(79). The most 
remarkable difference between the groups was related 
to the Lactobacilli count, especially Lactobacillus iners, 
which was higher in healthy men, compared to prosta-
titis patients.(79)
In another study on 30 patients, urine and fecal sam-
ples were collected before and after transrectal biopsy 
of the prostate. DNA was extracted from the urine after 
prostate massage and before and after prostate biopsy. 
DNA was also extracted from fecal samples before bi-
opsy. Lactobacillus and Staphylococcus bacteria were 
observed in the urinary microbial profiles before biop-
sy. The count of Lactobacillus decreased, whereas in-
creased levels of Prevotella bacteria were detected in 
the urinary microbial profiles after biopsy. The results 
showed that Bacteroides bacteria were predominant in 
the fecal samples.(80)
Microbiome and Detrusor Underactivity (DU) / 
Underactive Bladder Syndrome
DU is among the most common conditions causing 
LUTS. It is associated with a variety of interactions 
between the brain and the bladder at different levels, 
resulting in diminished voiding efficiency and bladder 
acontractility.(81) It is described as failure to reach com-
plete bladder emptying in a normal time span and/or ex-
tended duration of bladder emptying, caused by a con-
traction of reduced strength and/or duration.(82) Based 
on our literature review, no study has yet focused on the 
relationship between DU and urinary tract microbiome; 
therefore, further research is warranted in this area. 
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Microbiome and Urolithiasis
The presence of microbiome in patients with kidney 
stones has been detected by examining the content of 
stone microflora, using PCR and standard microbio-
logical methods.(83) Calcium oxalate is a major element 
in the composition of kidney stones. Accordingly, 
urinary oxalate is considered a risk factor for kidney 
stones. This microorganism, along with the intestinal 
microbiome, contributes to the pathogenesis of kidney 
stones. Oxalobacter formigenes is a Gram-negative 
bacterium, which decreases oxalates in the gut, lead-
ing to the reduction of oxalate excretion.(84) There is a 
correlation between urinary microbiome and formation 
of struvite stones, as urease production, involved in 
struvite stone formation, is the sole function of bacteria 
in urinary stone disease (USD).(85) On the other hand, 
recent studies have shown that some bacteria, including 
S. epidermidis, E. cloacae, E. coli, and L. gasseri, are 
associated with stones of a non-struvite composition. 
These bacterial species in the urine can adhere to stones 
or contribute to the formation of stones.(86) 
Moreover, a significant bacterial diversity, including 
Enterobacteriaceae, Gardnerella, and Lactobacillus 
species, has been detected in a recent study, using NGS 
sequencing technologies.(87) In this study, the murine 
kidney calcium oxalate deposits were induced by E. 
coli, and the kidneys were transurethrally inoculated 
with uropathogenic E. coli. The assumption that renal 
calcium oxalate deposits can be an amendable risk fac-
tor for kidney and urinary tract infections should not 
be dismissed, as bacteria may be adjacent to calcium 
oxalate deposits and induce positive effects on calcium 
oxalate renal disease.(87) It is also suggested to consider 
the kidney stone microbiome in predicting the recursive 
behavior of kidney stones; however, this suggestion 
must be further examined.(64)
Bacteriotherapy, which can be used to eliminate oxa-
lates and reduce the risk of USD, has shown limited 
success. Similarly, oxalate-decreasing probiotics do 
not yield favorable results. Common shifts in the gut 
microbiota and a diverse microbial network, associated 
with oxalate metabolism, may play a role in the onset 
of USD. However, it is important to consider the corre-
lation between the gut microbiota and USD rather than 
solely focusing on a specific functional microbial spe-
cies. We can develop a more successful bacteriotherapy 
by adjusting it to target a broad range of bacteria rather 
than only a few selected species.(88)
Microbiome and Urothelial Carcinoma 
Some findings support the hypothesis that members of 
the genitourinary microbiota are causative factors or 
cofactors in genitourinary cancers. So far, the informa-
tion related to gastrointestinal microbes is mainly used 
for identifying cancer treatment responses. It must be 
noted that therapeutic options for genitourinary cancers 
may be affected by the human-associated microbio-
ta. Urothelial carcinoma is the most common type of 
cancer in the urinary tract, and the bladder is the most 
frequently affected area.(89) Infections caused by Schis-
tosoma haematobium are associated with the develop-
ment of squamous cell carcinoma of the bladder due to 
chronic inflammation. In this regard, a previous study 
suggested that microbiota are possible contributors to 
the pathogenesis of several chronic diseases, such as 
cancer. In both men and women, the Firmicutes were 
found, while actinomycetes, including Mycobacteria 
and Bacteroidetes, were only found in women.(9) Nev-
ertheless, the relationship between UTI and urothelial 
carcinoma has not been established yet.
The Bacillus Calmette–Guerin (BCG) vaccine, which 
prevents tuberculosis, has been used to prevent the re-
currence of bladder cancer.(5) This vaccine is identified 
as a Mycobacterium, and therefore, it is an actinomy-
cete. Controversial studies have proposed the same 
potential for L. casei, as a bacterium from the phylum 
Firmicutes in the urinary microbiota.(5) Microbiota, pri-
marily composed of actinomycetes, may account for 
the lower occurrence of bladder cancer in women, as 
actinomycetes can have preventive effects, similar to 
BCG, which is known to influence the treatment and 
prevention of bladder cancer relapse; therefore, we 
must reconsider the prevention and risk factors of blad-
der cancer.(90,91)
In this regard, a microbiome study was conducted on 
urine samples collected from six healthy subjects and 
eight urothelial carcinoma patients, using the 454 se-
quencing technology. A total of 329 genera were doc-
umented. Acinetobacter was the most frequent genus, 
while Streptococcus, Pseudomonas, Finegoldia, Gard-
nerella, Anaerococcus, Escherichia, and Enterococcus 
were the most abundant genera in certain specimens. 
In the mentioned study, there was almost no Streptococ-
cus species in the majority of healthy samples, with the 
exception of one outlier. On the other hand, the Strep-
tococcus count increased in five out of eight cancer 
patients. Pseudomonas or Anaerococcus was the most 
dominant genus in two out of three cancer patients, with 
a low abundance of Streptococcus; these results suggest 
that urothelial carcinoma may be correlated with the al-
tered microbiota of the urinary tract.(92) However, the 
association of UTI with urothelial carcinoma is yet to 
be attested. Accumulating evidence suggests that indig-
enous microbiota in the urinary tract may play a signif-
icant role in the tumorigenesis of urothelial carcinoma, 
similar to other tumors.(93)
Additionally, another study examined the possible uri-
nary microbial community, which might be correlated 
with bladder cancer. The mid-stream urine samples 
were collected from 31 male patients with bladder can-
cer and 18 non-neoplastic controls. DNA was extract-
ed from the urine pellet specimens and processed for 
high-throughput 16S rRNA amplicon sequencing at V4 
region in an Illumina MiSeq system. The results indi-
cated the increase of some bacterial genera (e.g., Acine-
tobacter, Anaerococcus, and Sphingobacterium) and 
reduction of some other genera (e.g., Serratia, Proteus, 
and Roseomonas) in the cancer group, compared to the 
non-cancer group. The enrichment of Herbaspirillum, 
Porphyrobacter, and Bacteroides was detected in cancer 
patients, with potential recurrence and progression of 
the disease, which indicates that these genera are poten-
tial biomarkers for risk stratification.(93) 
Moreover, the Phylogenetic Investigation of Communi-
ties by Reconstruction of Unobserved States (PICRUS) 
demonstrated the enrichment of several functional path-
ways in the cancer group, including S. aureus infection, 
glycerolipid metabolism, and retinol metabolism. How-
ever, this study could not show whether changes in the 
microbiome contribute to cancer or vice versa. A more 
comprehensive understanding of the role of microbi-
ome in the progression and evolution of bladder cancer 
can help us investigate new therapeutic options and bi-
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omarkers.(93)
Microbiome and Prostate Cancer
A previous study assessed the possible correlation be-
tween bacteria and prostate cancer by investigating the 
type of microbiota in the expressed prostatic secretions 
(EPS) of patients with prostate cancer and benign pros-
tatic hyperplasia (BPH). The results showed a signif-
icant increase in Bacteroidetes, Alphaproteobacteria, 
Firmicutes, Lachnospiraceae, Propionicimonas, Sphin-
gomonas, and Ochrobactrum, whereas Eubacterium 
and Defluviicoccus decreased in the prostate cancer 
group, compared to the BPH group. Also, E. coli de-
creased significantly in the urine of the prostate cancer 
group, despite an increase in the EPS and seminal fluid. 
On the other hand, the Enterococci count considerably 
increased in the seminal fluid, with limited alterations 
in the urine and EPS.(95)
DISCUSSION
Today, it is generally accepted that the urine of healthy 
individuals is not sterile. Evidence shows that the blad-
der contains microbiomes, which are not detectable 
under standard conditions. The benefits or pathogenic 
roots of microbiomes are dependent on their charac-
teristics. Various studies have been published in recent 
years to determine the relationship between microbiome 
and LUTS. In these studies, urine was collected using a 
transurethral catheter to elude the urine from bacterial 
contamination by external tissues. To determine the res-
ident microbes, bacterial 16S rRNA was amplified us-
ing PCR assays. Also, NGS sequencing was performed 
in an Illumina MiSeq system. In all studies concentrat-
ing on the relationship between microbiome and OAB, 
the Lactobacillus count increased in OAB patients, 
compared to subjects without OAB. (4,29,32,69) 
So far, no study has examined the relationship between 
the urinary tract microbiome and DU. The urinary mi-
crobiome is a novel concept, which has attracted the 
attention of medical researchers. Since its introduction, 
many research teams, by conducting multiple fruitful 
studies, have changed our perspective toward the role 
of bacteria in the urinary tract and our perception of the 
genitourinary system health. 
Implications for Future Research
Many questions remain to be answered in this area. We 
need to determine how microorganisms interact with 
one another or with the host. We also need to specify 
the role of non-bacterial microbes and their stability 
in the urinary microbiota. Moreover, it is important to 
know whether the urinary microbiota changes through-
out the individual’s life, whether it responds to diet, and 
whether it is resilient or not. Also, we must characterize 
the actual role of urinary microbiota and determine if it 
interacts with the urothelium. Finally, it is important to 
understand whether modifications of the urinary micro-
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